Drugs / CY — 200 mg/m\^2 administered IV on Day 1 of Cycles 1 and 2
CY — 200 mg/m\^2 administered IV on Day 1 of Cycles 1 and 2
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02243371 Background | Jan 2015 → Jul 2017 | pancreatic adenocarcinoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CY — 200 mg/m\^2 administered IV on Day 1 of Cycles 1 and 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02243371 ↗ |
| Route | Intravenous | “200 mg/m\^2 administered IV on Day 1 of Cycles 1 and 2” NCT02243371 ↗ |